Articles & Video
The EU MDR Delay and Implementation - MedTech eBook Series
Discover the challenges of EU MDR implementation and impacts of the delay on the medical device industry in this MedTech eBook.
MedTech Report 2020: EU MDR and IVDR Compliance
Download the MedTech Report 2020 on EU MDR and IVDR Compliance, based on 265 survey responses from industry insiders.
Your Questions Answered: Understanding the role of Person Responsible for Regulatory Compliance
The TEAM-PRRC EU Association answer your questions on understanding the role of Person Responsible for Regulatory Compliance (PRRC) under the EU MDR.
REPORT: Diversity, Equity and Inclusion in the Life Sciences 2021
Explore the Diversity, Equity and Inclusion in the Life Sciences 2021 report based on an exclusive study of 483 industry professionals.
Clinical expectations of the EU MDR with TÜV SÜD and MedSmart
Clinical expectations of the EU MD: Matthias Fink from TÜV SÜD, and Dona Occhipinti from MedSmart discuss in this exclusive video interview.
The Journey to EU MDR Implementation - MedTech eBook Series
We answer some of the questions around EU MDR implementation in this MedTech Series eBook.
How the changing EUDAMED timeline impacts implementation of the EU MDR - with Eudamed.eu CEO Richard Houlihan
Richard Houlihan, CEO of EUDAMED.EU, discussed the EUDAMED modules status and the impact on implementing the EU MDR in this exclusive interview.
SURVEY: Diversity, Equity and Inclusion in the Life Sciences 2021
Complete our survey on Diversity, Equity and Inclusion in the Life Sciences 2021 to get exclusive early access to the final report.
Changes to the ISO 10993-23 and its impact on the medical device industry with NAMSA
Don Pohl from NAMSA discusses the changes to ISO 10993-23 in vitro guidance and what it means for the medical device industry.
EU Notified Body Association Takes Steps to Allay EC's Virtual Audit Fears
Amanda Maxwell looks at how the EU Notified Body Association is helping allay virtual audit fears.
MDR and IVDR: Onsite or offsite audits? That’s the question.
We examine the latest requirements with regard to Notified Bodies’ audits performed in the context of quality management system (QMS) assessment.
EU IVDR Preparation and Implementation - MedTech eBook Series
EU IVDR Preparation and Implementation: Discover Industry, Notified Body and Competent Authority perspectives in this MedTech Summit eBook.
REPORT: Adoption of AI and Digital Solutions in the MedTech Industry
This exclusive report looks at how AI and digital solutions have been adopted in the MedTech industry, and what the future looks like.
MedTech Summit 2020 Post-Event Report
Find the latest on EU MDR, IVDR and medical device law in this MedTech Summit 2020 Post-Event Report.
Is your Regulatory Information Management process putting your company at risk?
Many companies are putting themselves at risk lacking AI -powered RIM systems for regulatory data management. Get the details in this complimentary article.
Survey: Adoption of AI and Digital Solutions in the MedTech Industry
Take part in our study to discover the adoption of AI and digital solutions in the MedTech industry.
Clinical Evaluations for Medical Devices and IVDs - MedTech eBook Series
Discover how the EU MDR will affect clinical evaluations for medical devices and IVDs in this MedTech Summit eBook.
Report: Partnering And Deal-Making in Pharma through the Pandemic
This Informa report explores how partnering and deal-making in the pharma industry has been impacted by COVID-19.
REPORT: The Future of Healthcare Post COVID-19
In our latest report learn how healthcare organizations are adapting to succeed post COVID-19, from innovation to product development.
Women in Pharma: 44% of pharma professionals think that women are under represented in their organization
44% of pharma professionals think that women are under represented in their organization according to new data from an Informa Connect Life Sciences study. Here we deep dive into the data.
Barriers and Challenges for Global Regulatory Harmonization
What obstacles are keeping regions such as Latin America from achieving regulatory harmonization with the rest of the world?
Pharma R&D Annual Review 2020
The researchers and analysts at Pharma Intelligence have taken the guess work out of figuring out how pharmaceutical research and development has progressed over the past few years and what you can expect in 2020. Pharma R&D Annual Review 2020 condenses the thorough analysis of all drugs in development by pharmaceutical companies, from those at the preclinical stage, through the various stages of clinical testing and regulatory approval, and up to and including launch.